Scholar Rock Holding Corporation (SRRK) – What Are Analysts Thinking About This Stock?

Scholar Rock Holding Corporation (NASDAQ:SRRK) has been given an average recommendation of “Moderate Buy” by the seventeen research firms that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, one has given a hold recommendation, ten have issued a buy recommendation and four have given a strong buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $67.67.

SRRK has been the subject of several recent research reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Scholar Rock in a research report on Friday, July 17th. Barclays lowered Scholar Rock from an “overweight” rating to a “cautious” rating in a research report on Tuesday, September 15th. BMO Capital Markets upped their price objective on Scholar Rock from $76.00 to $84.00 and gave the stock an “outperform” rating in a research report on Monday, September 14th. Wedbush reiterated an “outperform” rating and issued a $64.00 price objective on shares of Scholar Rock in a research note on Tuesday, September 15th. Finally, UBS Group reiterated a “buy” rating on shares of Scholar Rock in a report on Tuesday, September 15th.

Institutional Investors Weigh In On Scholar Rock

Several large investors have recently bought and sold shares of the stock. BlackRock Inc. acquired a new stake in Scholar Rock in the 2nd quarter valued at about $522,175,000. Redmile Group LLC boosted its stake in shares of Scholar Rock by 73.7% in the 1st quarter. Redmile Group LLC now owns 9,066,621 shares of the company’s stock valued at $445,715,000 after buying an additional 3,845,775 shares during the period. Jennison Associates LLC grew its position in shares of Scholar Rock by 19.5% during the first quarter. Jennison Associates LLC now owns 3,340,492 shares of the company’s stock worth $164,219,000 after buying an additional 545,304 shares in the last quarter. Jupiter Topco LLC acquired a new position in shares of Scholar Rock during the second quarter worth about $123,279,000. Finally, Janus Henderson Group PLC grew its position in shares of Scholar Rock by 26.1% during the first quarter. Janus Henderson Group PLC now owns 2,236,837 shares of the company’s stock worth $109,891,000 after buying an additional 462,669 shares in the last quarter. Hedge funds and other institutional investors own 91.08% of the company’s stock.

Scholar Rock Trading Down 3.4%

Shares of SRRK stock opened at $40.52 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 7.02 and a current ratio of 7.02. The stock has a market capitalization of $4.93 billion, a P/E ratio of -11.74 and a beta of 0.61. The company has a 50 day moving average price of $51.41 and a 200 day moving average price of $49.96. Scholar Rock has a fifty-two week low of $27.07 and a fifty-two week high of $61.76.

Scholar Rock (NASDAQ:SRRK) last announced its earnings results on Thursday, August 6th. The company reported ($0.84) earnings per share for the quarter, hitting the consensus estimate of ($0.84). During the same quarter in the previous year, the company earned ($0.98) EPS. Equities research analysts predict that Scholar Rock will post -3.23 EPS for the current fiscal year.

About Scholar Rock

Scholar Rock Holding Corporation (NASDAQ: SRRK) is a clinical-stage biopharmaceutical company focused on developing medicines that selectively target the activation of growth factors. The company’s approach is designed to modulate biologic pathways in specific tissues while potentially limiting effects elsewhere in the body.

Scholar Rock’s lead product candidate is apitegromab, a monoclonal antibody designed to inhibit the activation of myostatin, a protein that negatively regulates muscle growth.